← Open Payments lookup

JENNIFER CAMPOLI: Open Payments

NPI 1205201530 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,979 in 41 payments from 25 companies in 2025. Trend: 2023 $941 · 2024 $609 · 2025 $1,979

Food & beverage: $1,310Consulting: $570Education: $99
CompanyPaymentsAmount
Legend Biotech USA Inc.1$570
Janssen Biotech, Inc.4$340
Gilead Sciences, Inc.3$142
GENZYME CORPORATION2$140
Novartis Pharmaceuticals Corporation3$67
E.R. Squibb & Sons, L.L.C.2$65
JAZZ PHARMACEUTICALS INC.2$62
Daiichi Sankyo Inc.2$57
BeOne Medicines USA, Inc.2$54
Genentech USA, Inc.2$51

Products named: CARVYKTI, RYBREVANT, Trodelvy, SARCLISA, ENHERTU, OPDIVO, ZEPZELCA, BRUKINSA.

Industry payments across DE — which companies pay providers there.